1 | F 18 T807 | - | - | - | - | 1件: 127 127 |
2 | F-18 | - | - | - | - | 2件: 5 5, 127 |
3 | F-18 3F4AP | - | - | - | - | 1件: 13 13 |
4 | F-18 AV 1451 | - | - | - | - | 1件: 5 5 |
5 | F-18 FDG | 1件: Pittsburgh Compound B Pittsburgh Compound B | - | - | - | 1件: 127 127 |
6 | F-18 FEDAA1106 (BAY85-8101) | - | - | - | - | 1件: 13 13 |
7 | F-18 FPCIT | - | - | - | - | 1件: 6 6 |
8 | F-A-F-A (FIASP-NovoRapid-FIASP-NovoRapid) | - | - | - | - | 1件: 299 299 |
9 | F13CD | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
10 | F8IL10 | - | - | - | - | 2件: 46 46, 97 |
11 | F8VR | 1件: Antihemophilic factor human Antihemophilic factor human | - | - | - | 1件: 288 288 |
12 | FAB122 | 1件: Edaravone Edaravone | 1件: D01552
D01552
| - | - | 1件: 2 2 |
13 | FABRAZYME | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
14 | Fabrazyme (agalsidase beta) | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
15 | FABRAZYME - 35 MG POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE ENDOVENOSA 1 FLACONCINO | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
16 | Fabrazyme 35 mg | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
17 | Fabrazyme 5 mg | 1件: Agalsidase beta Agalsidase beta | 1件: D03228
D03228
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
18 | FACTANE 200 IU/ml | 1件: Antihemophilic factor human Antihemophilic factor human | - | - | - | 1件: 288 288 |
19 | Factor VIII | 1件: ANX-510 ANX-510 | - | - | - | 1件: 288 288 |
20 | Factor VIII concentrate | 1件: ANX-510 ANX-510 | - | - | - | 1件: 288 288 |
21 | Factor von Willebrand | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
22 | FACTOR X | 1件: Coagulation factor X human Coagulation factor X human | - | - | - | 1件: 288 288 |
23 | Factor XIII | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 3件: 51 51, 97, 288 |
24 | Factor XIII Concentrate (Human) | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
25 | Factor XIII Concentrate (Human), Pasteurized | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
26 | Faecal matter | - | - | - | - | 1件: 97 97 |
27 | Faecal Microbiota Transplant | - | - | - | - | 1件: 97 97 |
28 | Faecal microbiota transplantation | - | - | - | - | 5件: 46 46, 84, 96, 97, 271 |
29 | Faecal sampling | - | - | - | - | 1件: 46 46 |
30 | FAM Therapy | - | - | - | - | 1件: 228 228 |
31 | FamC-1 | - | - | - | - | 1件: 2 2 |
32 | Famciclovir | 1件: Famciclovir Famciclovir | 1件: D00317
D00317
| - | - | 1件: 13 13 |
33 | FAMOTIDINA | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 61 61 |
34 | Famotidine | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 6件: 6 6, 46, 86, 98, 107, 300 |
35 | Famotidine 20 MG | 1件: Famotidine Famotidine | 1件: D00318
D00318
| 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 1件: 86 86 |
36 | FAMPRIDINA | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
37 | FAMPRIDINE | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 13 13, 14 |
38 | Fampridine SR | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
39 | Fampridine-SR | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
40 | Fampridine-SR b.i.d. (Twice Daily) | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
41 | FAMPYRA | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 13 13, 14 |
42 | FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14) | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
43 | Fampyra 10 mg prolonged-release tablets | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
44 | Fampyra 10mg prolonged release tablets | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
45 | Fan beam CT scan | - | - | - | - | 1件: 49 49 |
46 | Fang yi qing feng shi granule | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
47 | FANG(30) | - | - | - | - | 1件: 46 46 |
48 | Fanhdi | - | - | - | - | 1件: 288 288 |
49 | FANHDI 100 UI | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
50 | Fanhdi 100 UI FVIII-120 UI FVW | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
51 | FANHDI 25 UI | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
52 | Fanhdi 25 UI FVIII-30 UI FVW | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
53 | FANHDI 250UI*1F 250UI+F 10ML | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
54 | FANHDI 50 UI | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
55 | Fanhdi 50 UI FVIII-60 UI FVW | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
56 | FANHDI*INF FL 250UI+SIR SOLV+S | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
57 | FANHDI*INF FL 500UI+SIR SOLV+S | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
58 | FANHDI*INF FL1000UI+SIR SOLV+S | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
59 | FANHDI*INF FL250UI+SIR SOLV+S | 1件: Von Willebrand factor human Von Willebrand factor human | - | - | - | 1件: 288 288 |
60 | Fansidar (pyrimethamine and sulfadoxine) | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 1件: 65 65 |
61 | Fasenra | 1件: Benralizumab Benralizumab | 1件: D09874
D09874
| 1件: IL5RA IL5RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 5件: 44 44, 45, 98, 162, 299 |
62 | Faslodex | 1件: Fulvestrant Fulvestrant | 1件: D01161
D01161
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 49 49 |
63 | Fasudil | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 5, 7, 51 |
64 | Fasudil (WP-0512) | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
65 | FASUDIL HYDROCHLORIDE | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
66 | Fat diet | - | - | - | - | 1件: 78 78 |
67 | Fatigue | 1件: Testosterone Testosterone | 6件: D00075
D00075
,
D00957
,
D00958
,
D00959
,
D06085
,
D06087
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 |
68 | FAXE Kondi | - | - | - | - | 1件: 257 257 |
69 | Faxe Kondi Free | - | - | - | - | 1件: 257 257 |
70 | FB-101 | - | - | - | - | 1件: 6 6 |
71 | FB704A | - | - | - | - | 1件: 46 46 |
72 | FBL-MTX | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
73 | FBS0701 | - | - | - | - | 1件: 284 284 |
74 | FBS0701 CAPSULE | - | - | - | - | 1件: 284 284 |
75 | FBS0701/SSP004184 | - | - | - | - | 1件: 284 284 |
76 | FBX-101 | - | - | - | - | 1件: 19 19 |
77 | Fc- and CDR-modified humanised monoclonal antibody against C5 | - | - | - | - | 3件: 11 11, 62, 109 |
78 | FCM | 1件: Fosfomycin Fosfomycin | 4件: D00925
D00925
,
D02187
,
D02188
,
D04253
| - | - | 2件: 63 63, 222 |
79 | FCN-159 | - | - | - | - | 1件: 34 34 |
80 | FCR001 | - | - | - | - | 1件: 51 51 |
81 | FCX-007 (dabocemagene autoficel | - | - | - | - | 1件: 36 36 |
82 | FDC macitentan/tadalafil | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
83 | FDG | 1件: Methionine Methionine | 2件: D00019
D00019
,
D04983
| - | - | 1件: 84 84 |
84 | FDG-PET | 1件: Dimercaprol Dimercaprol | 1件: D00167
D00167
| - | - | 1件: 299 299 |
85 | FDL169 | - | - | - | - | 1件: 299 299 |
86 | FDL176 | - | - | - | - | 1件: 299 299 |
87 | FDL176 & FDL169 coadministration | - | - | - | - | 1件: 299 299 |
88 | FE 992097 | - | - | - | - | 1件: 193 193 |
89 | FE 999301 | - | - | - | - | 2件: 96 96, 97 |
90 | Feburane | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 1件: 21 21 |
91 | Febuxostat | 1件: Inosine Inosine | 1件: D00054
D00054
| - | - | 3件: 2 2, 6, 13 |
92 | Fecal Microbial transplant | 1件: Omeprazole Omeprazole | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 96 96, 97 |
93 | Fecal microbial transplant (FMT) | - | - | - | - | 1件: 13 13 |
94 | Fecal Microbial Transplantation | - | - | - | - | 2件: 96 96, 97 |
95 | Fecal Microbial Transplants | - | - | - | - | 1件: 13 13 |
96 | Fecal microbiota | - | - | - | - | 3件: 13 13, 96, 97 |
97 | Fecal microbiota capsule | - | - | - | - | 1件: 97 97 |
98 | Fecal Microbiota Enema | - | - | - | - | 1件: 97 97 |
99 | Fecal Microbiota Transplant | - | - | - | - | 2件: 96 96, 97 |
100 | Fecal Microbiota Transplant (FMT) | - | - | - | - | 2件: 96 96, 97 |
101 | Fecal microbiota transplantation | 1件: Vancomycin Vancomycin | 2件: D00212
D00212
,
D00926
| - | - | 5件: 2 2, 66, 94, 96, 97 |
102 | Fecal Microbiota Transplantation (FMT) | - | - | - | - | 2件: 96 96, 97 |
103 | Fecal Microbiota Transplantation (FMT) of FMP30 Donor Stool | - | - | - | - | 1件: 13 13 |
104 | Fecal Microbiota Transplantation (FMT), OpenBiome | - | - | - | - | 1件: 97 97 |
105 | Felzartamab | 1件: Felzartamab Felzartamab | - | - | - | 1件: 66 66 |
106 | Femoston 1/10 | 1件: Dydrogesterone Dydrogesterone | 1件: D01217
D01217
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
107 | Femoston 2/10 | 1件: Dydrogesterone Dydrogesterone | 1件: D01217
D01217
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 13 13 |
108 | Fendrix | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
109 | Fendrix suspension for injection | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
110 | Fendrix suspension for injection Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed). | 1件: Hepatitis B Vaccine (Recombinant) Hepatitis B Vaccine (Recombinant) | - | - | - | 1件: 46 46 |
111 | FENEBRUTINIB | 1件: Teriflunomide Teriflunomide | 1件: D10172
D10172
| 1件: DHODH DHODH 💬 | 3件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬 | 1件: 13 13 |
112 | Fenfluramina | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 140 140, 144 |
113 | Fenfluramina Cloridrato | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 140 140, 144 |
114 | FENFLURAMINE | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 140 140, 144, 145, 149 |
115 | Fenfluramine HCl, DL-Fenfluramine, (±)-Fenfluramine | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 144 144 |
116 | FENFLURAMINE HYDROCHLORIDE | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 140 140, 144 |
117 | FENFLURAMINE HYDROCHLORIDE (colorless) | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 140 140, 144 |
118 | FENFLURAMINE HYDROCHLORIDE (red) | 1件: Fenfluramine Fenfluramine | 1件: D07945
D07945
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 140 140 |
119 | Fengshigutong Capsule | 1件: Imrecoxib Imrecoxib | - | - | - | 1件: 271 271 |
120 | Fengshigutong Capsule plus Imrecoxib | 1件: Imrecoxib Imrecoxib | - | - | - | 1件: 271 271 |
121 | Fenilbutirato | - | - | - | - | 1件: 2 2 |
122 | Fenofibrate | 1件: Fenofibrate Fenofibrate | 1件: D00565
D00565
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 5件: 8 8, 79, 93, 94, 265 |
123 | Fenofibrate IDD-P (Insoluble Drug Delivery-Micro Particle) | 1件: Fenofibrate Fenofibrate | 1件: D00565
D00565
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件: 93 93 |
124 | Fenretinide | 1件: Fenretinide Fenretinide | 1件: D04162
D04162
| 2件: RARA RARA, RARB 💬 | 8件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 299 299 |
125 | Fentanyl | 1件: Lorazepam Lorazepam | 1件: D00365
D00365
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 4件: 46 46, 70, 215, 231 |
126 | Fentanyl (High Dose) | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
127 | Fentanyl (Low Dose) | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
128 | Fentanyl (Low Dose) + Dexmedetomidine | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 215 215 |
129 | Fentanyl transdermal patch | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
130 | Feraheme | 1件: Ferumoxytol Ferumoxytol | 1件: D04177
D04177
| - | - | 1件: 13 13 |
131 | Ferinject | 1件: Iron Dextran Iron Dextran | 1件: D02141
D02141
| - | - | 2件: 86 86, 299 |
132 | Ferinject or CosmoFer | 1件: Iron Dextran Iron Dextran | 1件: D02141
D02141
| - | - | 1件: 86 86 |
133 | Fermented oyster extract | 1件: Oyster Oyster | - | - | - | 1件: 84 84 |
134 | Ferric Carboxy Maltose | 1件: Maltose Maltose | 1件: D00044
D00044
| - | - | 1件: 96 96 |
135 | FERRIC CARBOXYMALTOSE | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: D08920
D08920
| - | - | 4件: 86 86, 96, 97, 299 |
136 | Ferric Maltol | 1件: Maltose Maltose | 1件: D00044
D00044
| - | - | 1件: 96 96 |
137 | Ferricarboxymaltose | - | - | - | - | 1件: 86 86 |
138 | Ferriprox | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 2件: 6 6, 120 |
139 | Ferriprox 500 mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
140 | FERRIPROX*100CPR RIV 500MG | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 120 120 |
141 | Ferrograd | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
142 | Ferrograd Folic Tablets | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
143 | Ferrous sulfate 325mg | 1件: Sulfate ion Sulfate ion | - | - | - | 1件: 299 299 |
144 | Ferrous sulphate | - | - | - | - | 2件: 96 96, 97 |
145 | Ferrous sulphate 200mg oral tablet | - | - | - | - | 1件: 227 227 |
146 | Ferrprox (Deferiprone) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
147 | Ferulic acid | 1件: Ferulic acid Ferulic acid | - | - | - | 1件: 127 127 |
148 | Ferumoxytol | 1件: Ferumoxytol Ferumoxytol | 1件: D04177
D04177
| - | - | 1件: 13 13 |
149 | Fesoterodine | 1件: Fesoterodine Fesoterodine | 1件: D07226
D07226
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
150 | Fetal porcine cells, Neurocell-PD | - | - | - | - | 1件: 6 6 |
151 | Fetal surgery for MMC repair | 1件: Mitomycin Mitomycin | 1件: D00208
D00208
| - | - | 1件: 118 118 |
152 | Fexinidazole | 1件: Fexinidazole Fexinidazole | 1件: D11252
D11252
| - | - | 1件: 65 65 |
153 | Fexofenadine | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 13 13, 46 |
154 | FFP104 | - | - | - | - | 2件: 93 93, 96 |
155 | FG-3019 | 1件: Pamrevlumab Pamrevlumab | 1件: D10969
D10969
| 1件: CCN2 CCN2 💬 | 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 3件: 85 85, 113, 222 |
156 | FG-3019 10mg/mL in 10 mL vials | 1件: Pamrevlumab Pamrevlumab | 1件: D10969
D10969
| 1件: CCN2 CCN2 💬 | 2件: Apelin signaling pathway Apelin signaling pathway, Hippo signaling pathway 💬 | 1件: 85 85 |
157 | Fibrate treatment | - | - | - | - | 1件: 160 160 |
158 | Fibrin | 1件: Fibrin Fibrin | - | - | - | 1件: 96 96 |
159 | Fibrin glue injection in fistula | 1件: Fibrin Fibrin | - | - | - | 1件: 96 96 |
160 | Fibrinogen | 1件: Fibrinogen human Fibrinogen human | - | - | - | 3件: 14 14, 65, 288 |
161 | Fibrinogen (coagulation factorI) | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 65 65 |
162 | Fibrinogen concentrate | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 14 14 |
163 | Fibrinogen Concentrate from Human Plasma | 1件: Fibrinogen human Fibrinogen human | - | - | - | 1件: 65 65 |
164 | Fibroblasts | - | - | - | - | 1件: 36 36 |
165 | Fibrogammin P | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
166 | Fibrogammin® 1250 | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 51 51 |
167 | Fibrogammin® P | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
168 | Fibrogammin®P | 1件: Factor XIII (human) Factor XIII (human) | - | - | - | 1件: 288 288 |
169 | Fibrogammin®P, coagulation factor XIII concentrate (Human) | 1件: Sodium chloride Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 51 51 |
170 | Fibroscan | 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 2件: 93 93, 171 |
171 | Fibrovein | 1件: Bleomycin Bleomycin | 3件: D02177
D02177
,
D03229
,
D07535
| - | - | 1件: 279 279 |
172 | Fibrovein 3% | 1件: Bleomycin Bleomycin | 3件: D02177
D02177
,
D03229
,
D07535
| - | - | 1件: 279 279 |
173 | Fig | 1件: Lactose Lactose | 2件: D00046
D00046
,
D03226
| - | - | 1件: 2 2 |
174 | Filamentous haemagglutinin | 1件: Aluminium Aluminium | - | - | - | 1件: 46 46 |
175 | Filamentous haemagglutinin adsorbed | 1件: Aluminium Aluminium | - | - | - | 1件: 46 46 |
176 | FILGOTINIB | 1件: Filgotinib Filgotinib | 1件: D10871
D10871
| 1件: JAK1 JAK1 💬 | 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 6件: 46 46, 53, 96, 97, 222, 271 |
177 | Filgotinib 200mg/day | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
178 | Filgrastim | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 28件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
179 | Filgrastim (G-CSF) | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 331 331 |
180 | Filgrastim Hexal | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 65 65 |
181 | Filgrastim, Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| - | - | 1件: 65 65 |
182 | Film-coated tablet | - | - | - | - | 1件: 97 97 |
183 | Finamine tablets | - | - | - | - | 1件: 6 6 |
184 | Finasteride | 1件: Finasteride Finasteride | 1件: D00321
D00321
| 1件: SRD5A2 SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 |
185 | Finely ground flaxseed powder | 1件: Flax seed Flax seed | - | - | - | 1件: 299 299 |
186 | Fingolimob | 1件: Fumaric acid Fumaric acid | 1件: D02308
D02308
| - | - | 1件: 13 13 |
187 | Fingolimob (FTY) | 1件: Natalizumab Natalizumab | 1件: D06886
D06886
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
188 | FINGOLIMOD | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 14, 156 |
189 | Fingolimod (FTY720) | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 156 |
190 | Fingolimod 0.5 mg | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
191 | Fingolimod 0.5mg | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
192 | Fingolimod 1.25 mg | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
193 | FINGOLIMOD HYDROCHLORIDE | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 2件: 13 13, 14 |
194 | Fingolimodi | - | - | - | - | 1件: 13 13 |
195 | Fingolmod | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
196 | Fipamezole | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
197 | Fipamezole hydrochloride | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
198 | Fipamezole hydrochloride 30 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
199 | Fipamezole hydrochloride 60 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
200 | Fipamezole hydrochloride 90 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
201 | Fipamezole ODT | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 |
202 | Fipamezole ODT Cohort 2 | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 |
203 | Firategrast | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
204 | Firategrast (USAN approved name) | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
205 | Firategrast 150 mg | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
206 | Firategrast 300 mg | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
207 | Firategrast gastro-retentive solution | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
208 | Firategrast immediate release tablet | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
209 | Firategrast modified release tablet | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
210 | Firdapse | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 |
211 | FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE | 1件: Amifampridine Amifampridine | 1件: D10228
D10228
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 3 3, 11 |
212 | First line DMT | 1件: Dimethyltryptamine Dimethyltryptamine | - | - | - | 1件: 13 13 |
213 | Fish Oil | 1件: Olive oil Olive oil | 1件: D03311
D03311
| - | - | 7件: 13 13, 46, 49, 66, 96, 260, 299 |
214 | Fish oil concentrate | 1件: Fish oil Fish oil | - | - | - | 1件: 13 13 |
215 | Fish oil supplement | 1件: Fish oil Fish oil | - | - | - | 1件: 46 46 |
216 | Fish oil, gamma-linolenic acid | 1件: alpha-Linolenic acid alpha-Linolenic acid | - | - | - | 1件: 46 46 |
217 | FISH OIL, RICH IN OMEGA-3-ACIDS | 1件: Beta carotene Beta carotene | 1件: D03101
D03101
| - | - | 1件: 13 13 |
218 | FISH OIL,RICH IN OMEGA 3 ACIDS | 1件: Beta carotene Beta carotene | 1件: D03101
D03101
| - | - | 1件: 13 13 |
219 | FITC-Adalimumab | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
220 | Fixed dose combination Ciprofloxacin/Celecoxib | 1件: Celecoxib Celecoxib | 1件: D00567
D00567
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 2 2 |
221 | FK-506 | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| - | - | 1件: 60 60 |
222 | FK506 | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 222 222 |
223 | FK506 level 2-3 ng/ml | - | - | - | - | 1件: 86 86 |
224 | FK506 level 3-5 ng/ml | - | - | - | - | 1件: 86 86 |
225 | FK506 level < 2 ng/ml | - | - | - | - | 1件: 86 86 |
226 | FKB327 | - | - | - | - | 1件: 46 46 |
227 | FKB327 AI | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
228 | FKB327 PFS | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
229 | Flagyl | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
230 | Flash glucose monitoring system | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 49 49 |
231 | Flavocoxid | - | - | - | - | 1件: 113 113 |
232 | Flavoxate | 1件: Flavoxate Flavoxate | 2件: D00718
D00718
,
D07961
| 16件: PDE10A PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 | 18件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
233 | Flaxseed | 1件: Flax seed Flax seed | - | - | - | 2件: 97 97, 299 |
234 | Flaxseed lignan-enriched complex (FLC) | 1件: Flax seed Flax seed | - | - | - | 1件: 97 97 |
235 | FLEBOGAMMA 5% | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 15 15 |
236 | Flebogamma 5% DIF | - | - | - | - | 1件: 65 65 |
237 | Flecainide | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 1件: 6 6 |
238 | FLECAINIDE ACETATE | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 1件: 6 6 |
239 | Flecainidum | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 1件: 6 6 |
240 | Flexible bronchoscopy in moderate sedation | 1件: Propofol Propofol | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 84 84 |
241 | Flixabi | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 |
242 | Flolan | 1件: Epoprostenol Epoprostenol | 2件: D00106
D00106
,
D01337
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
243 | FLOLAN injection with currently marketed diluent | 1件: Epoprostenol Epoprostenol | 2件: D00106
D00106
,
D01337
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
244 | FLOLAN injection with reformulated diluent | 1件: Epoprostenol Epoprostenol | 2件: D00106
D00106
,
D01337
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
245 | FLOLAN TM and Glycine Diluent | 1件: Glycine Glycine | 1件: D00011
D00011
| - | - | 1件: 86 86 |
246 | Flolan® | 1件: Epoprostenol Epoprostenol | 2件: D00106
D00106
,
D01337
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
247 | FLOLAN™ and Glycine Diluent | 1件: Glycine Glycine | 1件: D00011
D00011
| - | - | 1件: 86 86 |
248 | FLORBETABEN (18F) | 1件: Florbetaben (18F) Florbetaben (18F) | - | - | - | 1件: 6 6 |
249 | Florbetapir (18F) | 1件: Florbetapir (18F) Florbetapir (18F) | - | - | - | 1件: 127 127 |
250 | Florbetapir 18F | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 1件: 127 127 |
251 | Florbetapir 18F Injection | - | - | - | - | 1件: 127 127 |
252 | Florbetapir F 18 | - | - | - | - | 1件: 6 6 |
253 | Florence 30 µg/mL | - | - | - | - | 1件: 98 98 |
254 | Florence 60 µg/mL | - | - | - | - | 1件: 98 98 |
255 | Florence 90 µg/mL | - | - | - | - | 1件: 98 98 |
256 | Flortaucipir | 1件: Flortaucipir Flortaucipir | 1件: D11210
D11210
| 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 |
257 | Flortaucipir F18 | 1件: Flortaucipir Flortaucipir | 1件: D11210
D11210
| 1件: MAPT MAPT 💬 | 4件: Alzheimer disease Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 5 5, 7, 127 |
258 | Floseal | - | - | - | - | 1件: 227 227 |
259 | Flovent | - | - | - | - | 1件: 98 98 |
260 | Flow-mediated dilation of the brachial artery | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 1件: 49 49 |
261 | FLT190 | - | - | - | - | 1件: 19 19 |
262 | Flu-ATG | - | - | - | - | 1件: 60 60 |
263 | Flucinolone acetonide | - | - | - | - | 1件: 56 56 |
264 | FLUCLOXACILLIN | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
265 | Flucloxacillin 250mg/5ml Sugar-Free Powder for Oral Solution | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
266 | FLUCLOXACILLIN SODIUM | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
267 | Flucloxicillin | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
268 | FLUCONAZOLE | 1件: Fluconazole Fluconazole | 2件: D00322
D00322
,
D01429
| - | - | 2件: 96 96, 225 |
269 | FLUDARA | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
270 | Fludarabina | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 19 19, 65 |
271 | Fludarabina Accord | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 65 65 |
272 | FLUDARABINA ACCORD - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 5 FLACONCINI IN VETRO DA 2 ML | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 19 19 |
273 | FLUDARABINA FOSFATO | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 19 19 |
274 | FLUDARABINA TEVA - 25 MG/ML CONCENTRATO PER SOLUZIONE INIETTABILE O PER INFUSIONE 1 FLACONCINO DI VETRO DA 2 ML | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 65 65 |
275 | Fludarabine | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 18件: 13 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 |
276 | Fludarabine (FLU) | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 60 60, 285 |
277 | Fludarabine monophosphate | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| - | - | 3件: 65 65, 284, 326 |
278 | Fludarabine phosphate | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| - | - | 12件: 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 |
279 | Fludarabine phosphate 30 mg | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| - | - | 2件: 65 65, 164 |
280 | Fludarabine phosphate 40 mg | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| - | - | 2件: 65 65, 164 |
281 | Fludarabine, Busulfan, Thymoglobulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | - | - | - | 1件: 65 65 |
282 | Fludarabine, Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: D00287
D00287
,
D07760
| - | - | 1件: 60 60 |
283 | Fludarabine, Melphalan, Thiotepa | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 1件: 65 65 |
284 | Fludarabine/ melphalan | 1件: Busulfan Busulfan | 1件: D00248
D00248
| - | - | 1件: 60 60 |
285 | Fludarabine/busulfan | 1件: Busulfan Busulfan | 1件: D00248
D00248
| - | - | 1件: 60 60 |
286 | Fludeoxyglucose | 1件: Gadopentetic acid Gadopentetic acid | 2件: D01707
D01707
,
D08006
| - | - | 4件: 34 34, 84, 85, 88 |
287 | Fludeoxyglucose F 18 | 1件: Gadopentetic acid Gadopentetic acid | 2件: D01707
D01707
,
D08006
| - | - | 1件: 34 34 |
288 | Fludrocortisone | 1件: Flutamide Flutamide | 1件: D00586
D00586
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 3件: 6 6, 17, 81 |
289 | Fluimucil | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 4件: 85 85, 94, 193, 298 |
290 | Fluimucil (acetylcysteine) | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 193 193 |
291 | FLUIMUCIL*20CPR EFF 600MG | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 2件: 94 94, 298 |
292 | Fluimucil® 600 mg effervescent tablets | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 85 85 |
293 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
294 | FluMist | 1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen | - | - | - | 1件: 299 299 |
295 | Flumist® | 1件: Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen Influenza B virus B/Brisbane/60/2008 live (attenuated) antigen | - | - | - | 1件: 299 299 |
296 | Fluocinolone | 1件: Fluocinolone acetonide Fluocinolone acetonide | 1件: D01825
D01825
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
297 | Fluocinolone Acetonide | 1件: Fluocinolone acetonide Fluocinolone acetonide | 1件: D01825
D01825
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 90 90 |
298 | Fluorescein | 1件: Fluorescein Fluorescein | 2件: D01261
D01261
,
D02024
| - | - | 3件: 19 19, 22, 97 |
299 | Fluorescence endoscopy and spectroscopy | 1件: Vedolizumab Vedolizumab | 1件: D08083
D08083
| 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 96 96 |
300 | Fluorescence Imaging | - | - | - | - | 1件: 46 46 |
301 | Fluorescite | - | - | - | - | 1件: 215 215 |
302 | FLUORINE (18F) FLUDEOXYGLUCOSE | 1件: Methionine Methionine | 2件: D00019
D00019
,
D04983
| - | - | 2件: 84 84, 85 |
303 | FLUORINE-18 | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 1件: 41 41 |
304 | Fluorodeoxyglucose | 1件: Rubidium Rubidium | - | - | - | 1件: 84 84 |
305 | Fluoroscopic swallow evaluation | 1件: Capsaicin Capsaicin | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
306 | Fluoxetin | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 13 13, 179, 206 |
307 | Fluoxetin Hexal | 1件: Venlafaxine Venlafaxine | 2件: D00821
D00821
,
D08670
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 |
308 | FLUOXETINE | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 4件: 13 13, 17, 78, 86 |
309 | FLUOXETINE HYDROCHLORIDE | 1件: Venlafaxine Venlafaxine | 2件: D00821
D00821
,
D08670
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 13 13 |
310 | Fluoxétine | 1件: Fluoxetine Fluoxetine | 2件: D00326
D00326
,
D00823
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 17 17 |
311 | Flupentixol | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
312 | Flupirtin | 1件: Chlormezanone Chlormezanone | 1件: D00268
D00268
| - | - | 1件: 13 13 |
313 | Flupirtine | 1件: Flupirtine Flupirtine | 1件: D07978
D07978
| - | - | 1件: 13 13 |
314 | Flupirtinmaleat | 1件: Chlormezanone Chlormezanone | 1件: D00268
D00268
| - | - | 1件: 13 13 |
315 | FLURBIPROFEN | 1件: Omeprazole Omeprazole | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 3件: 13 13, 21, 46 |
316 | Flutamide | 1件: Flutamide Flutamide | 1件: D00586
D00586
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 81 81 |
317 | Flutemetamol | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
318 | Flutemetamol F18 | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
319 | Fluticasone | 1件: Fluticasone Fluticasone | 1件: D07981
D07981
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 98 98, 228, 299 |
320 | Fluticasone MDI | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
321 | FLUTICASONE PROPIONATE | 1件: Fluticasone propionate Fluticasone propionate | 1件: D01708
D01708
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 228 |
322 | Fluticasone Propionate, 800 mcg twice daily (post 4FED failure) | 1件: Fluticasone propionate Fluticasone propionate | 1件: D01708
D01708
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
323 | Fluticasone Propionate, 880 mcg twice daily (after 6FED failure) | 1件: Fluticasone propionate Fluticasone propionate | 1件: D01708
D01708
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
324 | Fluticasone Propionate, USP | 1件: Fluticasone propionate Fluticasone propionate | 1件: D01708
D01708
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
325 | Fluvastatin | 1件: Valsartan Valsartan | 1件: D00400
D00400
| 1件: AGTR1 AGTR1 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 79 79, 218, 222 |
326 | Fluzone | 1件: Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) | - | - | - | 2件: 21 21, 49 |
327 | Fluzone® | 1件: Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) | - | - | - | 1件: 21 21 |
328 | FLX-787-ODT | - | - | - | - | 1件: 2 2 |
329 | FLX-787-ODT (orally disintegrating tablet) | - | - | - | - | 1件: 10 10 |
330 | FLX-787-ODT (orally disintigrating tablet) | - | - | - | - | 1件: 2 2 |
331 | FMP-30 | - | - | - | - | 1件: 53 53 |
332 | FMP30 Donor Stool | - | - | - | - | 1件: 13 13 |
333 | FMT | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 2件: 96 96, 97 |
334 | FMT enema | - | - | - | - | 1件: 97 97 |
335 | FMT infusions | - | - | - | - | 1件: 97 97 |
336 | FMT oral | - | - | - | - | 1件: 97 97 |
337 | FMT+MTX | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
338 | Focetria | - | - | - | - | 1件: 46 46 |
339 | Focetria (Monovalent MF59-Adjuvanted vaccine) | - | - | - | - | 3件: 46 46, 49, 271 |
340 | Folate | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 13 13, 41, 46, 49 |
341 | FolateScan (Technetium Tc 99mEC20) | - | - | - | - | 4件: 13 13, 46, 49, 96 |
342 | Folic (or folinic) acid | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 256 |
343 | Folic acid | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 4件: 6 6, 46, 49, 84 |
344 | Folic acid or folate | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
345 | Folic Acid, Vitamin B6, Vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 1件: 6 6 |
346 | Folic/folinic acid | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 107 |
347 | Foliglurax | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
348 | Foliglurax 10 mg (treatment A) | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
349 | Foliglurax 30 mg (treatment B) | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
350 | Folimet | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 1件: 46 46 |
351 | Folinic acid | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 3件: 46 46, 107, 320 |
352 | Follow-up probiotic | - | - | - | - | 1件: 193 193 |
353 | Follow-up study of the treated cohort | - | - | - | - | 1件: 193 193 |
354 | Fontolizumab | 1件: Fontolizumab Fontolizumab | 1件: D04242
D04242
| 1件: IFNG IFNG 💬 | 32件: African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 46 46 |
355 | Foralumab | 1件: Foralumab Foralumab | - | - | - | 2件: 13 13, 96 |
356 | Forigerimod | 1件: Forigerimod Forigerimod | 1件: D09904
D09904
| - | - | 1件: 49 49 |
357 | FORLAX 4 g, poudre pour solution buvable en sachet | - | - | - | - | 1件: 299 299 |
358 | Formalin | 1件: Formaldehyde Formaldehyde | 1件: D00017
D00017
| - | - | 1件: 84 84 |
359 | Formistin | 1件: Cetirizine Cetirizine | 2件: D00664
D00664
,
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
360 | FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE | 1件: Cetirizine Cetirizine | 2件: D00664
D00664
,
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
361 | Formistin 10 mg | 1件: Cetirizine Cetirizine | 2件: D00664
D00664
,
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
362 | Formoterol | 1件: Formoterol Formoterol | 3件: D01373
D01373
,
D05277
,
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 85 85, 228, 299 |
363 | Formoterol fumarate dihydrate | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 2件: D00689
D00689
,
D07495
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
364 | Formoterol/Budesonide | 1件: Formoterol Formoterol | 3件: D01373
D01373
,
D05277
,
D07990
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 |
365 | Formulation A | - | - | - | - | 1件: 13 13 |
366 | Formulation B | - | - | - | - | 1件: 13 13 |
367 | Formulation C | - | - | - | - | 1件: 13 13 |
368 | Formulation D | - | - | - | - | 1件: 13 13 |
369 | Forsteo | 1件: Teriparatide Teriparatide | 1件: D06078
D06078
| 1件: PTH1R PTH1R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 3件: 70 70, 235, 274 |
370 | FORSTEO-R | 1件: Hydrochlorothiazide Hydrochlorothiazide | 1件: D00340
D00340
| - | - | 1件: 235 235 |
371 | FORTECORTIN | 1件: Lenalidomide Lenalidomide | 1件: D04687
D04687
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 28 28, 65 |
372 | Fortecortin Inject 40 mg Amp. | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
373 | Forteo | 1件: Parathyroid hormone Parathyroid hormone | 1件: D05364
D05364
| 2件: PTH1R PTH1R, PTH2R 💬 | 3件: Endocrine and other factor-regulated calcium reabsorption Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬 | 1件: 70 70 |
374 | Fortum | 1件: Flucloxacillin Flucloxacillin | 3件: D01249
D01249
,
D04196
,
D07965
| - | - | 1件: 299 299 |
375 | FOS | 1件: Adalimumab Adalimumab | 1件: D02597
D02597
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 66 66, 96 |
376 | Foscarbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
377 | Foscarbidopa and Foslevodopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
378 | Foscarnet | 1件: Foscarnet Foscarnet | 2件: D00579
D00579
,
D02267
| - | - | 2件: 28 28, 60 |
379 | Foscarnet sodium | 1件: Foscarnet Foscarnet | 2件: D00579
D00579
,
D02267
| - | - | 2件: 28 28, 60 |
380 | FosD | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 |
381 | Fosfamatinib Disodium | - | - | - | - | 1件: 46 46 |
382 | Fosfato sodico de dexametasona | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
383 | Fosfomycin | 1件: Fosfomycin Fosfomycin | 4件: D00925
D00925
,
D02187
,
D02188
,
D04253
| - | - | 2件: 96 96, 97 |
384 | FOSFOMYCIN DISODIUM | 1件: Fosfomycin Fosfomycin | 4件: D00925
D00925
,
D02187
,
D02188
,
D04253
| - | - | 1件: 97 97 |
385 | Foslevodopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
386 | Fosmetpantotenate | - | - | - | - | 1件: 120 120 |
387 | Fosmetpantotenate (RE-024) | - | - | - | - | 1件: 120 120 |
388 | FOSMETPANTOTENATE DRUG SUBSTANCE | - | - | - | - | 1件: 120 120 |
389 | Fosmetpantotenato | - | - | - | - | 1件: 120 120 |
390 | Fospropofol | 1件: Fospropofol Fospropofol | - | - | - | 1件: 226 226 |
391 | Fospropofol (Lusedra®) 10 | 1件: Fospropofol Fospropofol | - | - | - | 1件: 226 226 |
392 | Fospropofol (Lusedra®) 12 | 1件: Fospropofol Fospropofol | - | - | - | 1件: 226 226 |
393 | Fospropofol (Lusedra®) 6.5 | 1件: Fospropofol Fospropofol | - | - | - | 1件: 226 226 |
394 | Fostair | 1件: Beclomethasone dipropionate Beclomethasone dipropionate | 2件: D00689
D00689
,
D07495
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
395 | Fostamatinib | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 4件: 46 46, 49, 61, 66 |
396 | Fostamatinib 100 mg | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 |
397 | Fostamatinib 100 mg tablet | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 |
398 | Fostamatinib 150 mg | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 |
399 | Fostamatinib 150 mg bid | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 61 61 |
400 | Fostamatinib 150 mg tablet | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 |
401 | Fostamatinib 50 mg blue film-coated tablet | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 |
402 | Fostamatinib Disodium | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 3件: 46 46, 61, 66 |
403 | Fostamatinib Disodium (R935788) | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 2件: 46 46, 49 |
404 | Fostamatinib Disodium tablet 100 mg | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 |
405 | Fostamatinib Disodium tablet 150 mg | 1件: Fostamatinib Fostamatinib | 1件: D09347
D09347
| 1件: SYK SYK 💬 | 17件: B cell receptor signaling pathway B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬 | 1件: 66 66 |
406 | Four-point cane (FPC) | 1件: Ferric pyrophosphate citrate Ferric pyrophosphate citrate | 1件: D10933
D10933
| - | - | 1件: 13 13 |
407 | Fourier Domain Doppler Optical Coherence Tomography (FDOCT) | 1件: Sulodexide Sulodexide | 1件: D08547
D08547
| 2件: SERPINC1 SERPINC1, SERPIND1 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 13 13 |
408 | FP-045 | - | - | - | - | 1件: 285 285 |
409 | FP-110 | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 1件: 97 97 |
410 | FP-CYA-050 | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 |
411 | FP-CYA-053 | 1件: Cyclosporine Cyclosporine | 1件: D00184
D00184
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 97 97 |
412 | FPA008 | - | - | - | - | 1件: 46 46 |
413 | FPC | 1件: Ferric pyrophosphate citrate Ferric pyrophosphate citrate | 1件: D10933
D10933
| - | - | 1件: 13 13 |
414 | FPF 300 (thalidomide) | 1件: Thalidomide Thalidomide | 1件: D00754
D00754
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 16 16 |
415 | FPF1011 | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: D00163
D00163
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 263 263 |
416 | FPF1100NW | 1件: Selegiline Selegiline | 2件: D00785
D00785
,
D03731
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
417 | FPFS-1169 | 1件: Benzofuran Benzofuran | - | - | - | 1件: 6 6 |
418 | FR104 | - | - | - | - | 1件: 46 46 |
419 | Fractional carbon dioxide laser | 1件: Carbon dioxide Carbon dioxide | 1件: D00004
D00004
| - | - | 1件: 51 51 |
420 | Fractionated Carbon Dioxide (FCO2) Laser | 1件: Carbon dioxide Carbon dioxide | 1件: D00004
D00004
| - | - | 1件: 50 50 |
421 | Fragmin | 1件: Apixaban Apixaban | 1件: D03213
D03213
| 1件: F10 F10 💬 | 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 |
422 | Free amino acids intake | 1件: Amino acids Amino acids | - | - | - | 1件: 240 240 |
423 | Freeze-dried black raspberry powder | 1件: Raspberry Raspberry | 1件: D09179
D09179
| - | - | 1件: 97 97 |
424 | Freeze-Dried Sulfonated Human Normal Immunoglobulin (GGS) | 1件: Human immunoglobulin G Human immunoglobulin G | - | - | - | 3件: 14 14, 43, 45 |
425 | Fremanezumab | 1件: Fremanezumab Fremanezumab | 1件: D11055
D11055
| 1件: CALCA CALCA 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 2件: 124 124, 226 |
426 | Frequently Sampled Oral Glucose Tolerance Test and CGM | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
427 | Fresenius-Kabi) | - | - | - | - | 1件: 46 46 |
428 | Fresh Frozen Plasma | - | - | - | - | 1件: 5 5 |
429 | Fresolimumab | 1件: Fresolimumab Fresolimumab | 1件: D09620
D09620
| 3件: TGFB1 TGFB1, TGFB2, TGFB3 💬 | 35件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 3件: 51 51, 222, 274 |
430 | Frisium | 1件: Topiramate Topiramate | 1件: D00537
D00537
| 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 140 140 |
431 | FRISIUM*30CPS 10MG | 1件: Topiramate Topiramate | 1件: D00537
D00537
| 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 140 140 |
432 | FRM-0334 | - | - | - | - | 1件: 127 127 |
433 | From August 2020 'no additional treatment' | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 51 51 |
434 | FSME-IMMUN | 1件: Tick-borne encephalitis vaccine (whole virus, inactivated) Tick-borne encephalitis vaccine (whole virus, inactivated) | - | - | - | 1件: 46 46 |
435 | FT011 | 1件: Benzoic acid Benzoic acid | 1件: D00038
D00038
| - | - | 1件: 51 51 |
436 | FT011 100 mg | 1件: Benzoic acid Benzoic acid | 1件: D00038
D00038
| - | - | 1件: 51 51 |
437 | FT011 200 mg | 1件: Benzoic acid Benzoic acid | 1件: D00038
D00038
| - | - | 1件: 51 51 |
438 | FTI, AZLI | - | - | - | - | 1件: 299 299 |
439 | FTX-1821 | 1件: Losmapimod Losmapimod | 1件: D09639
D09639
| 4件: MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬 | 62件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | 1件: 113 113 |
440 | FTY720 | - | - | - | - | 2件: 13 13, 14 |
441 | FTY720D | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
442 | FTY720I | 1件: Fingolimod Fingolimod | 1件: D10001
D10001
| 1件: S1PR1 S1PR1 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 14 14 |
443 | Fucidin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
444 | Fucidin Tablets | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
445 | Fucose | 1件: Fucose Fucose | - | - | - | 1件: 65 65 |
446 | Full Spectrum vitamin | 1件: Riboflavin Riboflavin | 3件: D00050
D00050
,
D01622
,
D01913
| - | - | 1件: 13 13 |
447 | Fully human anti-interferon gamma monoclonal antibody | 1件: Emapalumab Emapalumab | 1件: D11120
D11120
| 1件: IFNG IFNG 💬 | 32件: African trypanosomiasis African trypanosomiasis, Allograft rejection, Amoebiasis, Antigen processing and presentation, Chagas disease, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hepatitis C, Herpes simplex virus 1 infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Leishmaniasis, Malaria, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Proteasome, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 107 107 |
448 | Fully human IgG2 lambda monoclonal antibody | - | - | - | - | 1件: 172 172 |
449 | Fully human monoclonal antibody directed against CXCL10 | - | - | - | - | 1件: 93 93 |
450 | Fully humanised, recombinant monoclonal antibody (IgG1) | - | - | - | - | 1件: 96 96 |
451 | Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody | - | - | - | - | 1件: 13 13 |
452 | Fultium-D3 800IU capsules | 1件: Pamidronic acid Pamidronic acid | 2件: D00941
D00941
,
D07281
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 |
453 | Fulvestrant | 1件: Fulvestrant Fulvestrant | 1件: D01161
D01161
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 86 86 |
454 | Fumaderm | 1件: Fumaric acid Fumaric acid | 1件: D02308
D02308
| - | - | 1件: 49 49 |
455 | Fumaderm® | 1件: Fumaric acid Fumaric acid | 1件: D02308
D02308
| - | - | 1件: 49 49 |
456 | Fumaderm® initial | 1件: Fumaric acid Fumaric acid | 1件: D02308
D02308
| - | - | 1件: 49 49 |
457 | Fumaric acid | 1件: Fumaric acid Fumaric acid | 1件: D02308
D02308
| - | - | 1件: 13 13 |
458 | Functional hepatic nitrogen clearance | 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 1件: 171 171 |
459 | Functional Magnetic Resonance Imaging | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
460 | FURESTEM-RA Inj | - | - | - | - | 1件: 46 46 |
461 | FURESTEM-RA Inj. | - | - | - | - | 1件: 46 46 |
462 | Furosemide | 1件: Furosemide Furosemide | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
463 | Furosemide Injection | 1件: Furosemide Furosemide | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
464 | FUSIDIC ACID | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
465 | Fusidin | 1件: Doxycycline Doxycycline | 5件: D00307
D00307
,
D02129
,
D03903
,
D03904
,
D07876
| - | - | 1件: 299 299 |
466 | Fusion | 1件: Iron polymaltose Iron polymaltose | - | - | - | 7件: 11 11, 13, 46, 49, 69, 70, 271 |
467 | Fuzhenghuayu | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 93 93 |
468 | Fx-1006A | 1件: Fx-1006A Fx-1006A | - | - | - | 1件: 28 28 |
469 | FX125L | - | - | - | - | 1件: 46 46 |
470 | FXIII Concentrate (Human) | - | - | - | - | 1件: 288 288 |
471 | FXIII Concentrate (Human) (FXIII) | - | - | - | - | 1件: 288 288 |
472 | Fycompa | 1件: Perampanel Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 144 |